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Abstract
Background: Our research group advanced a health insurance theory to explain Canada’s cancer care advantages
over America. The late Barbara Starfield theorized that Canada’s greater primary care-orientation also plays a
critically protective role. We tested the resultant Starfield-Gorey theory by examining the effects of poverty, health
insurance and physician supplies, primary care and specialists, on colon cancer care in Ontario and California.
Methods: We analyzed registry data for people with non-metastasized colon cancer from Ontario (n = 2,060) and
California (n = 4,574) diagnosed between 1996 and 2000 and followed to 2010. We obtained census tract-based
socioeconomic data from population censuses and data on county-level physician supplies from national
repositories: primary care physicians, gastroenterologists and other specialists. High poverty neighborhoods were
oversampled and the criterion was 10 year survival. Hypotheses were explored with standardized rate ratios (RR)
and tested with logistic regression models.
Results: Significant inverse associations of poverty (RR = 0.79) and inadequate health insurance (RR = 0.80) with
survival were observed in the California, while they were non-significant or non-existent in Ontario. The direct
associations of primary care physician (RRs of 1.32 versus 1.11) and gastroenterologist (RRs of 1.56 versus 1.15)
supplies with survival were both stronger in Ontario than California. The supply of primary care physicians took
precedence. Probably mediated through the initial course of treatment, it largely explained the Canadian
advantage.
Conclusions: Poverty and health insurance were more predictive in the USA, community physician supplies more
so in Canada. Canada’s primary care protections were greatest among the most socioeconomically vulnerable. The
protective effects of Canadian health care prior to enactment of the Affordable Care Act (ACA) clearly suggested
the following. Notwithstanding the importance of insuring all, strengthening America’s system of primary care will
probably be the best way to ensure that the ACA’s full benefits are realized. Finally, Canada’s strong primary care
system ought to be maintained.
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Background
Our research group has studied cancer care among the
poor in the USA and Canada and consistently observed
Canadian advantages [1–5]. In fact, the more impover-
ished the people and places the larger the Canadian ad-
vantages. For example, we studied breast cancer in the
poorest neighborhoods of California and Ontario [6–8].
Five-year survival rates differed by 20 percent or more,
universal health insurance accounting for most of the
Canadian advantage [1, 9]. Our premise has been that
focusing on the experiences of the most vulnerable
people in the most vulnerable places magnifies clinical,
policy and human significance.
The late, preeminent primary care researcher and ad-
vocate, Barbara Starfield, commented that “insurance is
a necessary, but not sufficient explanation” [10–12]. She
theorized that Canada’s greater primary care-orientation
is also significantly protective. Her theory is consistent
with our observation of much greater primary care phys-
ician (PCP) representation among the physician work-
force of Ontario (47 %) than California (27 %) [13]. A
combined Starfield-Gorey theory of Canada-USA health
care postulates the following. First, personal income and
health insurance, well-known to be highly predictive of
health care quality in the USA, matter less in Canada’s
guaranteed-access system. Second, community health
care endowments, especially the supply of PCPs, matter
more in Canada.
We tested the Starfield-Gorey theory with a historical
study of breast cancer care in California and Ontario dur-
ing the pre-Affordable Care Act (ACA) era [Gorey KM
et al., unpublished observations, 2015]. The first Canada-
USA study to examine the independent effects of poverty,
health insurance and PCP supply, it’s theoretically consist-
ent highlights follow. The association of poverty with sub-
optimum care was strong in the USA, but nonexistent in
Canada. The association PCP supply with optimum care
was stronger in Canada than in the USA, and the Canadian
advantages were completely explainable by better health
insurance and primary care. Notwithstanding the import-
ance of insuring all Americans, this study suggested a way
to further ensure ACA protections, that is, increase the
supply of PCPs. However, it was only one test of the theory.
The present study is a systematic replication with another
important health care quality indicator, colon cancer care.
Sensitive to social and economic forces, colon cancer
care is a useful quality sentinel for comparing health
care systems. The second leading cause of cancer death
in North America, its prognosis can be excellent with
early diagnosis and treatment [14–17]. Colon cancer
screening and investigative technologies as well as surgi-
cal and systemic treatments that matter in terms of sur-
vival have proliferated in Canada [18–22] and the USA
[23–30] with moderate to strong inverse socioeconomic
associations in the USA, but modest to nil or null ones
in Canada. Community PCP supply has been associated
with earlier diagnosis as well as better treatment and
survival in both countries [13, 31, 32]. However, because
of disparate analytic models and lack of control for po-
tentially potent confounds, the relative size of PCP
supply-colon cancer care and survival effects in each
country are not yet known. The few studies of specialist
physician effects have been less consistent. Two studies
in the USA suggested that increased specialist physician
supplies may lead to disparities in colon cancer care as
well as to other health disparities [32, 33]. Quite the op-
posite was observed in a Canadian study that found a
protective effects of gastroenterologist supply [13]. We
are not aware of any Canada-USA study of colon cancer
care that has examined the independent effects of poverty,
health insurance and physician supplies, PCPs and special-
ists. This controlled observational study will do so.
Methods
Study samples
We oversampled people who lived in poverty and were
diagnosed with colon cancer in Ontario and California
between 1996 and 2000 and followed them until enact-
ment of the ACA in 2010. Cohorts were 4,574 people in
California and 2,060 people in Ontario with the most
treatable, non-metastasized colon cancers. Those diagnosed
with stage IV disease according to the American Joint
Committee on Cancer were excluded [34]. Ontario and
California are among places with the most comprehensive
and valid colon cancer registries in the world [35–37]. Na-
tional death indexes were used by both registries.
Poverty, health insurance and physician supply measures
Since neither Ontario nor California registries collect
income data, we joined them to neighborhood data via
Statistics Canada (2001) and USA (2000) census tracts
[38, 39]. A third of participants in California were ran-
domly selected from high poverty neighborhoods where
30 % or more of the people were poor. Others were ran-
domly selected from middle (5-29 % poor) and low pov-
erty neighborhoods (<5 % poor). The Ontario sample
similarly overrepresented the lowest income neighbor-
hoods and then randomly selected from middle and high
income neighborhoods. Lowest income neighborhoods
in the two countries were quite similar. Median annual
household incomes in US dollars were only slightly lower
in California ($23,125) than Ontario ($24,175) [40]. Pri-
mary health insurers were defined in California as private
(included Medicare with private supplemental coverage),
public (Medicare alone or Medicaid) or none.
We then identified communities with relatively low to
high health care endowments characterized by physician
supplies. To do this we joined participants to county-
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level active physician data via the American Medical As-
sociation and Canadian Institute for Health Information
databases (2000–2001) [41–44]. PCPs were those who
reported their specialty area as general or family prac-
tice. Consistent with validated definitions and practice
patterns, general internists in the USA and emergency
family medicine physicians in Canada were also included
as PCPs. Physicians reporting the majority of their time
in specialized practice or who were board certified in
that specialty were so defined [45, 46]. Threshold effects,
below which the participants were less likely to survive,
were identified by exploring 0.5 physician increments
[47]: < 7.5 PCPs per 10,000 or 2 gastroenterologists (GE)
per 100,000 community inhabitants. Thresholds were not
observed for the supplies of overall specialist physicians or
for other specialists often involved in colon cancer care
such as general surgeons or oncologists.
Analysis
According to the Starfield-Gorey theory poverty is a
strong predictor of early death in the USA, while ad-
equate PCP supply better predicts long term survival in
Canada. These hypotheses involve interaction effects:
poverty-by-country and PCP supply-by-country. We
used a logistic regression model to test them [47]. We
estimated the strength of each predictor-10 year survival
relationship (e.g., increased survival odds associated with
PCP supply increases) adjusting for the effects of other
predictors as well as potential confounds. We accounted
for stage as well as initial surgery and chemotherapy
which were available in California, but that we had to
retrospectively collect from health records across On-
tario at considerable cost. Therefore we oversampled
California participants to serve as multiple “controls.” A
strategy to efficiently increase analytic power, it meant
that we could detect rate differences as small as 5 %
(2-tailed α = 0.05; power1 - β = 0.80) [48]. All variables,
except three, had less than 1 % missing data: number
of regional lymph nodes examined (2.4 %), wait time
for treatment (5.4 %) and tumor grade (8.9 %). Odds
ratios (OR) and confidence intervals (CI) were estimated
from regression statistics.
We also described significant interactions by compar-
ing within and between-country survival rates across
poverty and physician supply strata. We directly adjusted
rates using a standard population with the age and
stage characteristics of this study’s combined Ontario-
California sample. It was used to calculate age and
stage-standardized rates for the Ontario and California
samples. All rates were calculated per 100 participants
and reported as percentages. We used rate ratios (RR) for
comparisons with 95 % CIs derived from the Mantel-
Haenszel χ2 test. Further methodological details have been
published [13, 16, 49–52].
Results
Physician supply statistics are displayed in Table 1. First,
the supply of PCPs was greater in Ontario. There was 1
more PCP for every 10,000 Ontarians than Californians
(means of 7.8 and 6.8). Moreover, 4 of every 10 participant
in Ontario (39.6 %), but only 1 of every 10 in California
(11.9 %) lived in adequately supplied communities with
7.5 or more PCPs for every 10,000 inhabitants. Second,
the supply of specialists was much greater in California,
where there were 10 more specialist physicians for every
10,000 inhabitants than in Ontario (means of 17.8 and
7.5). Third, the supply of GEs was much greater in Califor-
nia. There were 2.4 more GEs for every 100,000 Califor-
nians than Ontarians (means of 3.2 and 0.8). Additionally,
nearly all in California (86.4 %) and few in Ontario (4.7 %)
lived in adequately supplied communities with at least 2
GEs per 100,000 inhabitants. Finally, the pattern for other
specialists was similar.
Testing the Starfield-Gorey theory
Interactions are depicted in Table 2. As hypothesized,
the inverse poverty-survival association was relatively
strong in California (RR = 0.79, 95 % CI 0.73, 0.86), but
not significant in Ontario. Consequently, among people
who lived in poverty, those in Ontario were 15 percent
more likely to survive for 10 years than were those in
California (RR = 1.15, 95 % CI 1.02, 1.30). The Canadians
were similarly advantaged when compared with their un-
insured or publicly-insured counterparts in the USA
(RR = 1.18, 95 % CI 1.09, 1.28). Again as hypothesized,
the direct PCP-survival association was strong in On-
tario (RR = 1.32, 95 % CI 1.19, 1.46), but modest in Cali-
fornia (RR = 1.11, 95 % CI 1.00, 1.23). Consequently, in
adequately supplied communities people in Ontario
were 13 % more likely to survive than were their
counterparts in California (RR = 1.13, 95 % CI 1.00,
1.28). High poverty neighborhoods in Ontario also
had (mean = 8.6, SD = 2.4), on average, more than 2 more
PCPs per 10,000 residents than did high poverty neighbor-
hoods in California (mean = 6.4, SD = 1.8); F (1, 2186) =
595.77, p < .001.
The GE supply by country interaction is depicted
in the bottom of Table 2. The direct GE supply-
survival association was larger in Ontario (RR = 1.56,
95 % CI 1.28, 1.91) than in California (RR = 1.15,
95 % CI 1.03, 1.28). Among those who lived in ad-
equately supplied communities with 2 or more GEs
for every 100,000 inhabitants, Ontarians were much
more likely to survive than Californians (RR = 1.40,
95 % CI 1.16, 1.70). Such communities in Ontario
also had (mean = 9.0, SD = 1.9), on average, nearly 2
more PCPs per 10,000 inhabitants than similar communi-
ties in California (mean = 7.2, SD = 2.0); F (1, 4028) =
92.40, p < .001.
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Primary care precedence
Logistic regressions of predictors of 10-year colon cancer
survival are displayed in Table 3. The first model shows
the significant affect of PCP supply (OR = 1.60) and the
interaction of PCP supply and country (OR = 1.95) on
survival odds, while country itself had no affect. After
these factors and noted covariates entered the model no
other interactions entered. In model 2 we first entered
aspects of initial colon cancer care: receipt of surgical re-
section, number of lymph nodes surgically harvested for
pathological examination, receipt of adjuvant chemo-
therapy and wait times from diagnosis to surgery and
from surgery to chemotherapy. The still significant affect
of PCP supply (OR = 1.30) was attenuated and the PCP
supply by country interaction (OR = 1.11) was no longer
significant. Any Canadian primary care advantages were
probably realized through the initial course of treatment.
Primary care seems to have continued to offer protec-
tions in both countries throughout the years of follow-
up care.
Discussion
This systematic replication of cancer care in Ontario
and California found further support for the Starfield-
Gorey theory of Canada-USA health care disparities.
Consistent with the theory, poverty and health insurance
Table 1 Physician densities in communities where people with colon cancer resided in California and Ontario, 2000
Physician specialization community density California Ontario
Sample Percentage Sample Percentage
Primary care physicians per 10,000 inhabitants
1.9 to 5.9 2,003 34.7 1,000 37.0
6.0 to 7.4 3,086 53.4 631 23.4
7.5 to 18.0 687 11.9 1,069 39.6
M = 6.8 (SD = 2.0) M = 7.8 (SD = 2.2)
Mdn = 6.8 (range: 0.0–18.0) Mdn = 7.3 (range: 5.00–15.0)
Specialist physicians per 10,000 inhabitants
0.0 to 9.9 839 14.0 2,112 78.6
10.0 to 19.4 2,189 37.0 576 20.8
19.5 to 53.5 2,748 49.0 12 0.6
M = 17.8 (SD = 7.5) M = 7.5 (SD = 5.3)
Mdn = 19.4 (range: 0.0–53.5) Mdn = 6.1 (range: 0.0–25.0)
Gastroenterologists per 100,000 inhabitants
0.00 to 1.99 825 13.6 2,558 95.3
2.00 to 3.24 1,846 32.4 142 4.7
3.25 to 8.50 3,105 53.9 0 0.0
M = 3.2 (SD = 1.2) M = 0.8 (SD = 0.8)
Mdn = 3.3 (range: 0.0–8.5) Mdn = 0.5 (range: 0.0–2.7)
General Surgeons per 100,000 Inhabitants
0.00 to 6.24 519 8.7 2,416 89.4
6.50 to 10.49 2,554 43.9 263 10.1
10.50 to 27.25 2,703 47.4 21 0.5
M = 10.1 (SD = 3.1) M = 4.5 (SD = 1.8)
Mdn = 10.4 (range: 0.0–27.2) Mdn = 4.1 (range: 0.0–10.8)
Oncologists per 100,000 inhabitants
0.00 to 1.99 1,252 20.7 1,217 45.3
2.00 to 3.24 2,004 34.7 1,441 52.8
3.25 to 13.25 2,520 44.6 42 1.9
M = 3.0 (SD = 1.4) M = 1.6 (SD = 1.5)
Mdn = 3.1 (range: 0.00–9.50) Mdn = 2.0 (range: 0.0–13.3)
Notes. 8,476 people diagnosed with colon cancer between 1996 and 2000: 5,776 in California and 2,700 in Ontario. All between-country differences were statistically
significant at p < .001
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were more predictive in the USA, community PCP sup-
ply more so in Canada. Additionally, Canada’s primary
care protections were greatest among the most socioeco-
nomically vulnerable; those who lived in poverty or were
at greatest risk of being inadequately insured. In fact,
PCPs were more prevalent and more effective in the
poorest Canadian than in the poorest American neigh-
borhoods. These historical observations of the protective
effects of Canadian health care prior to enactment of the
ACA affirmed that strengthening America’s system of
primary care will probably be necessary to ensure full
realization of ACA benefits. Increased privatization is an
omnipresent consideration in Canada. This study also
strongly suggested that adding a second, private tier to
Canadian health care would only serve to reproduce the
socioeconomic disparities observed in the USA. Canadian
patients covered by single payer Medicare did as well as
privately insured patients in the USA.
Gastroenterologist supply was also relatively more pro-
tective in Ontario than California. In absolute terms, how-
ever, its impact was probably much greater in California
where most study participants lived in adequately supplied
communities. Few Ontario participants lived in such com-
munities. Additionally, PCPs were more prevalent in high
gastroenterologist density Canadian communities than
they were in similarly well-supplied American communi-
ties. The case mix of adequate physician supplies, primary
care and key specialists, seemed potentiating. Protections
attributable to PCP supply probably reinforce the protect-
ive effects of gastroenterologist supply. However, primary
care took precedence as it explained most of the Canadian
survival advantage we observed. This study systematically
replicated evidence of a more effective primary care sys-
tem in Canada. Its policy implications are: (1) chances for
the success of health insurance reforms in the USA will be
greatly increased by concomitant reforms to strengthen
primary care and (2) Canada’s primary care system ought
to be maintained and strengthened in the few places where
it may be vulnerable [53–55].
Our research is consistent with that suggesting Medicaid
expansion may not be enough to ensure access among the
poor or near poor [Gorey KM et al., unpublished observa-
tions, 2015, 56]. Oregon’s Medicaid experiment found that
expansion caused an increase in emergency room visits,
including visits for conditions treatable by PCPs. It also in-
creased PCP office visits as well as the use of preventive
services and it drastically reduced catastrophic health care
expenditures [57, 58]. An adequate supply of participating
PCPs seems central. Prospective study of primary care in
Canada along with primary care trends in diverse post-
Table 2 Effects of interactions of neighborhood poverty, health insurance, community physician supplies and country on 10-year
survival of non-metastasized colon cancer: California and Ontario, 1996—2010
California Ontario
Baseline 10-Year survival Rate ratio 10-Year survival Rate ratio Canada/United States
Observed group Sample Rate, % 95 % CI Sample Rate, % 95 % CI Rate ratio 95 % CI
Less than 30 % vs 30 % or more of households poor in neighborhood
Lower poverty 3,078 42.1 1,368 40.4 0.96 0.89, 1.03
High poverty 1,496 33.3 0.79 692 38.2 0.95 1.15 1.02, 1.30
0.73, 0.86 0.86, 1.05
Privately insured vs uninsured or publicly insured
Private 2,065 40.8 2,060 38.7 0.95 0.88, 1.02a
Uninsured or public 2,509 32.8 0.80 1.18 1.09, 1.28a
0.74, 0.86
Less than 7.5 vs 7.5 or more primary care physicians per 10,000 population in community
Lower PCP density 4,032 38.5 1,238 36.4 0.95 0.88, 1.02
High PCP density 542 42.8 1.11 822 48.2 1.32 1.13 1.00, 1.28
1.00, 1.23 1.19, 1.46
Less than 2 vs 2 or more gastroenterologists per 100,000 population in community
Lower GE density 651 35.9 1,953 37.0 1.03 0.92, 1.16
High GE density 3,923 41.2 1.15 107 57.6 1.56 1.40 1.16, 1.70
1.03, 1.28 1.28, 1.91
Notes. 6,634 incident non-metastasized cases diagnosed between 1996 and 2000 were followed to 2010: 4,574 in California and 2,060 in Ontario. Rates were
directly adjusted for age and stage using the California-Ontario population of cases as the standard (age categories: 25–59, 60–69, 70–79 and 80 and older; stage
categories: I, II and III). Statistically significant rate ratios are bolded. The adjusted very early diagnosis (stage I) rate of 27.4 % did not differ between-countries. The
adjusted 10-year survival rate of 39.2 % did not differ between-countries
aBoth groups in the USA were compared with the Canadian group all of whom were Medicare covered
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ACA communities across America will substantially aug-
ment trial findings and identify ways to maximize
ACA protections. Prospective study of specialized care,
gastroenterology for colon cancer care [59–62] and di-
verse specialist physicians for other health domains will
also be needed to fully inform physician supply policies in
both countries.
Future research needs
The primary care-based Canadian advantage on survival
was largely mediated by access to a more effective initial
course of treatment, typically provided during the first
six months to a year after diagnosis. But primary care
seemed to continue to be beneficial in both countries
throughout this study’s remaining nine years of follow-
up. This is consistent with studies in Canada and the
USA that have observed associations between PCP
visits and high quality follow-up care of cancer survivors
[63–66]. The cancer registries we studied, however, did
not provide data on follow-up care so we were not able to
study the effects of poverty, insurance and physician sup-
plies on longer term, follow-up care. Such studies are
needed to advance understandings of the entire colon can-
cer care process and to facilitate evidence-based decision
making and policy planning in the post-ACA era in both
countries.
Our research group has systematically replicated
and affirmed the Starfield-Gorey theory for Canada-
USA comparisons of colon and breast cancer care.
We invite independent research teams to test the the-
ory across other health care processes and outcomes.
Such knowledge will help policy makers to empirically
plan future PCP and specialist physician supplies, en-
abling the highest quality health care. We continue to
study cancer care among those who live in poverty,
now prospectively in diverse, including so-called “red”
and “blue” states.
Potential limitations
Our findings may not be generalizable to all Americans and
Canadians. However, because one in three Canadians lives
in Ontario and one in ten Americans lives in California, we
think they have ample external validity [67, 68]. Admittedly,
we purposefully oversampled those who lived in poverty so
our findings are most representative of their experiences.
Furthermore, California’s expanded Medicaid program is
more liberal than most states’ so estimates of health care in-
equities among the poor there are probably underestimates
of the nation’s [69–71].
Some may question our choice of overall, rather than
cancer-specific survival. Our rationales follow. First, can-
cer seemed the underlying cause of death among the
vast majority of participants in Ontario and California.
However, although vital status and length of survival are
highly accurate in North American cancer registries, the
underlying cause of death is not [37, 72–74]. We avoided
bias that would intrude through such, often substantial,
death certificate error by focusing on overall survival.
Second, the underlying cause of deaths not identified as
cancer deaths can still be associated with lack of treatment
or with their complications [75]. Furthermore, overall sur-
vival is the gold standard in most trials and the principle
that guides most oncologic practice [76, 77]. Recall that
participants were diagnosed with non-metastasized dis-
ease, imminently treatable in most cases. It seems likely
that the guiding principle among most participants and
their physicians was to maximally extend life. Therefore,
we think overall survival is the most policy-telling, prac-
tical indicator of clinical and human significance. Finally,
because our analysis had a hierarchical structure, with in-
dividuals nested within neighborhoods and counties, some
readers may wonder why we did not use a multi-level re-
gression model. Each key neighborhood and county-based
variable was constituted by only two clusters. And germi-
nal literature concurs that multi-level models should not
be estimated with data consisting of fewer than 10 clus-
ters. There has been some debate about the exact criterion
of “too few,” but sensitivity analyses strongly suggested to
us that two would definitely be too few [78, 79]. Other
potential limitations have been discussed [13, 16, 52].
Table 3 Logistic regression of main effects and interaction of
community primary care physician density and country on
10-year survival of non-metastasized colon cancer: California
and Ontario, 1996—2010
Predictor variables Odds
ratio
95 % Confidence
interval
Model 1: community primary care physician density and country
Country 0.94 0.82, 1.09
Community primary care physician
(PCP) density
1.60 1.30, 1.96
Community PCP density by country 1.95 1.50, 2.52
Model 2: colon cancer care variables entered
Had surgical resection 3.12 1.64, 5.93
>15 regional lymph nodes examined 1.23 1.07, 1.41
Received chemotherapy 1.28 1.00, 1.63
Waited > 90 days for treatmentsa 0.69b 0.45, 1.07
Country 0.98 0.88, 1.11
Community primary care physician
(PCP) density
1.30 1.06, 1.60
Community PCP density by country 1.11 0.82, 1.50
Notes. Total samples were 6,043 for model 1 and 5,908 for model 2. All effects
were adjusted for age, tumor stage and grade, and place (small or large urban
or rural). Gender did not enter either model so this pattern is likely the same
for women and men. Statistically significant odds ratios are bolded
aTotal wait time = wait after diagnosis for surgery + wait after surgery
for chemotherapy
bApproached significance, 90 % confidence interval (CI) = 0.48, 1.00
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Conclusions
As the Starfield-Gorey theory hypothesized, poverty and
health insurance were more predictive in the USA, com-
munity physician supplies more so in Canada. Canada’s
primary care protections were greatest among the most
socioeconomically vulnerable. This historical study of
the protective effects of Canadian health care prior to
enactment of the ACA clearly suggested that notwith-
standing the importance of insuring all, strengthening
America’s system of primary care will probably be the
best way to ensure that the ACA’s full benefits are realized.
As for Canada, its strong primary care system ought to be
maintained.
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